Stocktoria
Moleculin Biotech, Inc. MBRX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2016-06-02
Moleculin Biotech, Inc. statistics & valuation
Market cap$17.4M
P / B1.2×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -151.7% | -153.9% | -77.9% | -50.5% | -18.9% |
| Return on equity | -223.6% | -232.4% | -96.3% | -55.6% | -20.1% |
| Current ratio | 1.41 | 0.97 | 3.86 | 9.46 | 20.02 |
Source: SEC EDGAR filings · CIK 0001659617 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.